
Moderna gets the ultimate Wall Street validation: It's being added to the S&P 500
CNN
Moderna, the biotech that became a household name with its Covid-19 vaccine, is getting the ultimate Wall Street validation: It's being added to the S&P 500 index.
S&P made the announcement late Thursday, and shares of Moderna (MRNA) surged 10% Friday morning on the news. The stock is now up nearly 175% this year, giving Moderna a market valuation of more than $100 billion. Moderna's addition to the S&P 500 means that the scores of passively managed mutual funds and exchange-traded funds that mirror the S&P 500 will need to add the company's stock to their portfolios. That's a key reason that the stock was popping Friday.
Janet Mills and her allies are counting on a gender gap to narrow Platner’s wide lead ahead of the June 9 primary to decide who will face incumbent Republican Sen. Susan Collins. They are betting that the unfiltered style that has brought Platner widespread attention as someone who could help Democrats reach young men will backfire with women.

As a shrinking number of Transportation Security Administration agents work to keep hourslong security lines moving despite not being paid, President Donald Trump stepped into the fray Saturday, announcing he will send Immigration and Customs Enforcement officers to airports by Monday if Congress doesn’t agree to a plan to end the partial government shutdown.











